


EuroVacc’s primary objectives
Promote vaccine research
To promote vaccine research against HIV and other infectious diseases by bridging the strength of academic research groups with industrial expertise
Facilitate and support phase I & II clinical trials in Europe
To facilitate and support phase I & II clinical trials in Europe to expedite translational research from discovery to clinical development;
Partner with other international initiative
To partner with other international initiatives and industry for down-stream development and phase IIb/III trials.
Development of safe and effective HIV vaccines
EuroVacc is a non-profit organization dedicated to the development of safe and effective vaccines against HIV and other infectious diseases, through promoting and fostering collaborations with world leading vaccine researchers and developers in both public and private sectors.
